TAXOTERE vs ZEJULA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 11, 2026·How we rate

Possible drug interaction. TAXOTERE and ZEJULA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	TAXOTERE	ZEJULA
Rating	70/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DOCETAXEL	NIRAPARIB TOSYLATE
Manufacturer	Sanofi Aventis US	Glaxosmithkline
Dosage forms	Injectable	Tablet
Drug class	Microtubule Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms	Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

taxotere zejula

Rating

70/100

72/100

Pharmacy pays

—

Type

Active ingredient

DOCETAXEL

NIRAPARIB TOSYLATE

Manufacturer

Sanofi Aventis US

Glaxosmithkline

Dosage forms

Injectable

Tablet

Drug class

Microtubule Inhibitor

—

Boxed warning

None

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Frequently asked questions

Which is better-rated, Taxotere or Zejula?

By our independent rating, Zejula scores higher — 3.6 vs 3.5 out of 5 for Taxotere. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Taxotere and Zejula?

Taxotere contains Docetaxel, while Zejula contains Niraparib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.